Institute of Inflammation and Ageing From basic science to clinical trials, we cover every aspect of research into inflammation, the role it plays in ageing and the response to trauma.
News 'Cell pores' discovery gives hope to millions of brain and spinal cord injury patients Scientists have discovered a new treatment to dramatically reduce swelling after brain and spinal cord injuries, offering hope to 75 million victims worldwide each year.
News A doctor’s view from the frontline - Patient care at the time of COVID and how routine health data can help
Posted 11 August 2020 Coronavirus-related children's diseases linked to blood cell changes A disease occurring in children and linked to COVID-19 has significant changes in white blood cells.
Posted 28 July 2020 Researchers discover chemical messenger that instructs tissue cells to become aggressive A University of Birmingham team have established that a chemical messenger released by blood vessels instructs tissue cells to become aggressive and destroy joints, a classic symptom of rheumatoid arthritis.
Posted 14 July 2020 UK children's intensive care units come together to offer first nationwide insight into new condition in children thought to be related to COVID-19 A UK study into critically ill children admitted to paediatric intensive care units with symptoms of a rare, new inflammatory syndrome, has offered the first nationwide insights into the true extent of the condition.
Posted 17 June 2020 Birmingham professor awarded prestigious Carol Nachman prize for Rheumatology Professor Christopher Buckley has been awarded the 2020 Carol Nachman prize based on outstanding innovate research activities in the field of rheumatology.
Posted 10 June 2020 First drugs announced in major COVID-19 drugs trial Two UK drugs companies will be the first to partner with the Universities of Birmingham and Oxford as part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with COVID-19.
Posted 08 June 2020 Birmingham designed test confirms COVID-19 as trigger for rare Kawasaki-like syndrome in children A test developed in Birmingham has offered evidence confirming COVID-19 to be the cause of a newly emerged multi-system inflammatory syndrome in children, who have tested negative for the virus by the PCR test.